Previous Story
LifeCodexx AG partners with LifeCell to launch rapid and affordable non-invasive prenatal DNA Testing (NIPT) in India
LifeCodexx AG, a pioneer in non-invasive prenatal DNA testing in Europe has announced its partnership with LifeCell, India’s leading mother & baby preventive health care provider, to bring PrenaTest® qNIPT™ testing for the first time to India.
The qNIPT™ technology that detects the presence of fetal trisomy 21 from maternal blood, received CE marking in December 2016 after a successful blinded clinical validation with close to 1000 samples demonstrating a 100% test concordance with results obtained from PrenaTest® based on next generation sequencing. Since applied in diagnostic laboratory routine, the novel qNIPT™ assay clearly demonstrates a significant cost-efficiency and rapid turnaround time compared to other NIPT techniques.
Reference: Groemminger,S.et al. J. Clin. Med. 2014, 3, 679- 692; doi:10.3390/jcm3030679
